ATE497698T1 - Proteaseresistentes ti-wachstumshormon freisetzendes hormon - Google Patents
Proteaseresistentes ti-wachstumshormon freisetzendes hormonInfo
- Publication number
- ATE497698T1 ATE497698T1 AT03793134T AT03793134T ATE497698T1 AT E497698 T1 ATE497698 T1 AT E497698T1 AT 03793134 T AT03793134 T AT 03793134T AT 03793134 T AT03793134 T AT 03793134T AT E497698 T1 ATE497698 T1 AT E497698T1
- Authority
- AT
- Austria
- Prior art keywords
- proteas
- resistant
- hormone
- growth hormone
- growth
- Prior art date
Links
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 title 1
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 title 1
- 241000208465 Proteaceae Species 0.000 title 1
- 101710142969 Somatoliberin Proteins 0.000 title 1
- 235000019419 proteases Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/166,356 US20040192593A1 (en) | 1999-07-26 | 2002-08-21 | Protease resistant ti-growth hormone releasing hormone |
| PCT/US2003/025975 WO2004018697A2 (en) | 2002-08-21 | 2003-08-19 | Protease resistant ti-growth hormone releasing hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE497698T1 true ATE497698T1 (de) | 2011-02-15 |
Family
ID=31946206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03793134T ATE497698T1 (de) | 2002-08-21 | 2003-08-19 | Proteaseresistentes ti-wachstumshormon freisetzendes hormon |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040192593A1 (de) |
| EP (1) | EP1573046B1 (de) |
| AR (1) | AR040891A1 (de) |
| AT (1) | ATE497698T1 (de) |
| AU (1) | AU2003265499A1 (de) |
| DE (1) | DE60336011D1 (de) |
| TW (1) | TWI331156B (de) |
| WO (1) | WO2004018697A2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002348417B9 (en) * | 2001-10-26 | 2010-02-04 | Baylor College Of Medicine | A composition and method to alter lean body mass and bone properties in a subject |
| EP1539959A2 (de) * | 2002-09-18 | 2005-06-15 | Centre Hospitalier de l'Université de Montréal (CHUM) | Ghrh-analoge |
| US7846720B2 (en) * | 2005-01-26 | 2010-12-07 | Vgx Pharmaceuticals, Inc. | Optimized high yield synthetic plasmids |
| US20100267635A1 (en) * | 2009-04-20 | 2010-10-21 | Theratechonolgies Inc. | Use of protease inhibitors and grf molecules in combination therapy |
| EP2421548A4 (de) * | 2009-04-20 | 2012-09-26 | Theratechnologies Inc | Verwendung von (hexenoyl-trans-3)hgrf(l-44)nh2 und simvastatin in einer kombinationstherapie |
| EP2841572B1 (de) | 2012-04-27 | 2019-06-19 | Duke University | Genetische korrektur mutierter gene |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| US10676726B2 (en) | 2015-02-09 | 2020-06-09 | Duke University | Compositions and methods for epigenome editing |
| WO2017066497A2 (en) | 2015-10-13 | 2017-04-20 | Duke University | Genome engineering with type i crispr systems in eukaryotic cells |
| US12214054B2 (en) | 2015-11-30 | 2025-02-04 | Duke University | Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use |
| EP3443081A4 (de) | 2016-04-13 | 2019-10-30 | Duke University | Crispr/cas9-basierte repressoren zur in-vivo-ausschaltung von gen-targets und verfahren zur verwendung |
| JP7490211B2 (ja) | 2016-07-19 | 2024-05-27 | デューク ユニバーシティ | Cpf1に基づくゲノム編集の治療適用 |
| US12509492B2 (en) | 2018-01-19 | 2025-12-30 | Duke University | Genome engineering with CRISPR-Cas systems in eukaryotes |
| CA3099958A1 (en) | 2018-04-16 | 2019-10-24 | The Trustees Of The University Of Pennsylvania | Compositions and methods for treating duchenne muscular dystrophy |
| TWI887234B (zh) | 2019-04-14 | 2025-06-21 | 美國公爵大學 | 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除 |
| CN112266924A (zh) * | 2020-01-03 | 2021-01-26 | 浙江理工大学绍兴生物医药研究院有限公司 | 一种利用大肠杆菌高效表达并分泌人生长激素的方法 |
| CA3260237A1 (en) | 2022-06-24 | 2023-12-28 | Tune Therapeutics, Inc. | Compositions, systems and methods for reducing low-density lipoprotein by targeted gene repression |
| WO2025221969A2 (en) | 2024-04-18 | 2025-10-23 | Sarepta Therapeutics, Inc. | Genetic constructs for gene editing |
| WO2026074494A1 (en) | 2024-10-03 | 2026-04-09 | Sarepta Therapeutics, Inc. | Modified viral capsids and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4233020A (en) * | 1979-03-13 | 1980-11-11 | Owens-Corning Fiberglas Corporation | Collapsible mandrel |
| US4223021A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4226857A (en) * | 1979-03-30 | 1980-10-07 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223020A (en) | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228158A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4223019A (en) * | 1979-03-30 | 1980-09-16 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4228156A (en) * | 1979-03-30 | 1980-10-14 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4224316A (en) * | 1979-03-30 | 1980-09-23 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
| US4410512A (en) * | 1981-12-28 | 1983-10-18 | Beckman Instruments, Inc. | Combinations having synergistic pituitary growth hormone releasing activity |
| US5134120A (en) * | 1984-08-03 | 1992-07-28 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance porcine weight gain |
| US5036045A (en) | 1985-09-12 | 1991-07-30 | The University Of Virginia Alumni Patents Foundation | Method for increasing growth hormone secretion |
| US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
| US4833166A (en) * | 1987-05-01 | 1989-05-23 | Grosvenor Clark E | Growth hormone releasing hormone complementary peptides |
| US4839344A (en) * | 1987-06-12 | 1989-06-13 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
| USRE33699E (en) * | 1987-07-09 | 1991-09-24 | International Minerals & Chemical Corp. | Growth hormone-releasing factor analogs |
| FR2622455B1 (fr) * | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes |
| US5023322A (en) * | 1988-08-31 | 1991-06-11 | Mta Kutatas-Es Szervezetelemzo Intezete | Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof |
| US5084442A (en) * | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
| US5756458A (en) * | 1989-06-16 | 1998-05-26 | Pharmacia & Upjohn Company | Stabilized potent GRF analogs |
| US5137872A (en) * | 1989-09-18 | 1992-08-11 | Pitman-Moore, Inc. | Growth hormone-releasing factor analogs |
| NZ238748A (en) * | 1990-06-29 | 1993-09-27 | Hoffmann La Roche | Growth hormone releasing factor (grf) analogues |
| US5486505A (en) * | 1990-07-24 | 1996-01-23 | Polygen Holding Corporation | Polypeptide compounds having growth hormone releasing activity |
| CA2084061A1 (en) * | 1991-04-09 | 1992-10-10 | Arthur M. Felix | Growth hormone releasing factor analogs |
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| US5298422A (en) * | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
| US5792747A (en) * | 1995-01-24 | 1998-08-11 | The Administrators Of The Tulane Educational Fund | Highly potent agonists of growth hormone releasing hormone |
| CA2218173A1 (en) * | 1995-04-14 | 1996-10-17 | The Administrators Of The Tulane Educational Fund | Analogs of growth hormone-releasing factor |
| CA2297375A1 (en) * | 1997-07-24 | 1999-02-04 | Valentis, Inc. | Ghrh expression system and methods of use |
| KR20020047096A (ko) * | 1999-07-26 | 2002-06-21 | 크로커 사무엘 에스 | 초활성 돼지 성장 호르몬 분비 호르몬 유사체 |
| WO2001066149A2 (en) * | 2000-03-03 | 2001-09-13 | Valentis, Inc. | Nucleic acid formulations for gene delivery and methods of use |
| AU2002348417B9 (en) * | 2001-10-26 | 2010-02-04 | Baylor College Of Medicine | A composition and method to alter lean body mass and bone properties in a subject |
-
2002
- 2002-08-21 US US10/166,356 patent/US20040192593A1/en not_active Abandoned
-
2003
- 2003-08-19 DE DE60336011T patent/DE60336011D1/de not_active Expired - Lifetime
- 2003-08-19 AT AT03793134T patent/ATE497698T1/de not_active IP Right Cessation
- 2003-08-19 WO PCT/US2003/025975 patent/WO2004018697A2/en not_active Ceased
- 2003-08-19 TW TW092122793A patent/TWI331156B/zh not_active IP Right Cessation
- 2003-08-19 AU AU2003265499A patent/AU2003265499A1/en not_active Abandoned
- 2003-08-19 EP EP03793134A patent/EP1573046B1/de not_active Expired - Lifetime
- 2003-08-20 AR AR20030103014A patent/AR040891A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003265499A1 (en) | 2004-03-11 |
| EP1573046A2 (de) | 2005-09-14 |
| US20040192593A1 (en) | 2004-09-30 |
| WO2004018697A3 (en) | 2006-02-16 |
| DE60336011D1 (de) | 2011-03-24 |
| EP1573046B1 (de) | 2011-02-09 |
| WO2004018697A2 (en) | 2004-03-04 |
| TW200416226A (en) | 2004-09-01 |
| EP1573046A4 (de) | 2007-05-02 |
| AR040891A1 (es) | 2005-04-20 |
| TWI331156B (en) | 2010-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1542716T3 (da) | Væksthormonfrigivende peptider | |
| NO20042182L (no) | Kjemisk-modifiserte veksthormonkonjugater | |
| ATE390898T1 (de) | Zwischenwirbelimplantat | |
| ATE394087T1 (de) | Zwischenwirbelimplantat | |
| ATE394086T1 (de) | Zwischenwirbelimplantat | |
| DE60312054D1 (de) | Prothese | |
| DE60327764D1 (de) | Anti-reflux harnleiter-stents | |
| DK1524272T3 (da) | Væksthormonsekretionsfremmere | |
| DE60336011D1 (de) | Proteaseresistentes ti-wachstumshormon freisetzendes hormon | |
| ATE496940T1 (de) | Ghrelin-analoga | |
| DE60313015D1 (de) | Künstlicher satellit | |
| DE60311192D1 (de) | Bildempfangsmaterial | |
| EP1500603A4 (de) | Ausgiessbehälter | |
| DK1548110T3 (da) | Transglutaminase-producerende stamme | |
| FR2843017B1 (fr) | Implant inter-somatique | |
| GB0222700D0 (en) | Rodent trap | |
| EP1483963A4 (de) | Falscher köder | |
| NO20023199L (no) | Punktmater | |
| ATA4422002A (de) | Ausleger | |
| FI20020655A0 (fi) | Astia | |
| NL1022386A1 (nl) | Palengrijper. | |
| GB0314413D0 (en) | Bait bucket | |
| ATA10802002A (de) | Verkürzungshaken | |
| ATE520370T1 (de) | Verbesserungen bezüglich stents | |
| UA7573S (uk) | Сечоприймач |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |